E-LIB Suche - Ergebnisse für: White, Darrell

1

Belantamab mafodotin, pomalidomide and dexamethasone in ref..:

Trudel, Suzanne ; McCurdy, Arleigh ; Louzada, Martha L....
Nature Medicine. 30 (2024) 2 - p. 543-551 , 2024

Link: https://doi.org/10.1038/..

2

Efficacy and safety of once weekly selinexor 40 mg versus 6..:

White, Darrell ; Schiller, Gary J. ; Madan, Sumit...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Long‐term follow‐up of outcomes including progression‐free ..:

Kaedbey, Rayan ; Reece, Donna ; Venner, Christopher P....
eJHaem. , 2024

Link: https://doi.org/10.1002/..

4

P-321 Real-world outcomes in myeloma patients with t(11;14)..:

Varghese, Julia ; Venner, Christopher ; Louzada, Martha...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S215 , 2023

Link: https://doi.org/10.1016/..

5

Selinexor-Based Triplet Regimens in Patients With Multiple ..:

Schiller, Gary J. ; Lipe, Brea C. ; Bahlis, Nizar J....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 9 - p. e286-e296.e4 , 2023

Link: https://doi.org/10.1016/..

6

P-291 Outcomes of third-line therapy in multiple myeloma pa..:

Louzada, Martha ; Reece, Donna ; Venner, Christopher...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S197 , 2023

Link: https://doi.org/10.1016/..

7

Redefining attrition in multiple myeloma (MM): a Canadian M..:

McCurdy, Arleigh ; Mian, Hira ; LeBlanc, Richard...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

8

Late versus early response and depth of response are associ..:

Richardson, Paul G. ; Facon, Thierry ; Venner, Christopher P....
eJHaem. 4 (2023) 4 - p. 995-1005 , 2023

Link: https://doi.org/10.1002/..

9

P-320 Iberdomide (IBER) plus dexamethasone (DEX) in patient..:

van de Donk, Niels ; White, Darrell ; Lipe, Brea...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S214-S215 , 2023

Link: https://doi.org/10.1016/..

10

Outcome of carfilzomib/pomalidomide‐based regimens after da..:

LeBlanc, Richard ; Mian, Hira ; Reece, Donna...
European Journal of Haematology. 111 (2023) 5 - p. 815-823 , 2023

Link: https://doi.org/10.1111/..

11

OA-49 Mezigdomide (MEZI) plus dexamethasone (DEX) and borte..:

Oriol, Albert ; Sandhu, Irwindeep ; Raab, Marc...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S31 , 2023

Link: https://doi.org/10.1016/..

12

Real-world results of autologous stem cell transplantation ..:

Côté, Julie ; LeBlanc, Richard ; Mian, Hira...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

OA-41 Iberdomide, bortezomib, and dexamethasone (IberVd) in..:

White, Darrell ; Lipe, Brea ; Mesa, Mercedes Gironella...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S25 , 2023

Link: https://doi.org/10.1016/..

14

Correction: Redefining attrition in multiple myeloma (MM): ..:

McCurdy, Arleigh ; Mian, Hira ; LeBlanc, Richard...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

15

P982: EFFICACY AND SAFETY OF 40 MG VS 60 MG OF ONCE WEEKLY ..:

White, Darrell ; Baljevic, Muhamed ; Schiller, Gary...
HemaSphere. 7 (2023) S3 - p. e899038f , 2023

Link: https://doi.org/10.1097/..